DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
TEPOTINIB HYDROCHLORIDE
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Carcinoma, Non-Small-Cell Lung
Hepatocyte growth factor receptor inhibitor
TEPOTINIB HYDROCHLORIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
VY5YX2TQ1F
Molecule Type:
Small molecule
Molecular Formula:
C29H31ClN6O3
Molecular Weight:
547.06
AlogP:
4.01
PSA:
96.93
HBD:
0.0
HBA:
#RotB:
7.0
Source:
ETHASELEN
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung
Unknown
ETHASELEN
×
Maximum Phase:
1
First Approval:
None
UNII:
4Q2EZS1IWG
Molecule Type:
Small molecule
Molecular Formula:
C16H12N2O2Se2
Molecular Weight:
422.2
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
BIAPENEM
1
Small molecule
Investigational
Unknown
Unknown
Bacterial Infections
Unknown
BIAPENEM
×
Maximum Phase:
1
First Approval:
None
UNII:
YR5U3L9ZH1
Molecule Type:
Small molecule
Molecular Formula:
C15H18N4O4S
Molecular Weight:
350.4
AlogP:
-1.89
PSA:
102.37
HBD:
1.0
HBA:
#RotB:
4.0
Source:
PF-05180999
1
Small molecule
Investigational
Unknown
Unknown
Migraine Disorders; Schizophrenia
Unknown
PF-05180999
×
Maximum Phase:
1
First Approval:
None
UNII:
5L84K4IEN9
Molecule Type:
Small molecule
Molecular Formula:
C19H17F3N8
Molecular Weight:
414.4
AlogP:
3.12
PSA:
77.03
HBD:
0.0
HBA:
#RotB:
3.0
Source:
ILX23-7553
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Vitamin D receptor agonist
ILX23-7553
×
Maximum Phase:
1
First Approval:
None
UNII:
O13QTC8612
Molecule Type:
Small molecule
Molecular Formula:
C27H38O3
Molecular Weight:
410.6
AlogP:
4.85
PSA:
60.69
HBD:
3.0
HBA:
#RotB:
3.0
Source:
LY-3009120
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Melanoma; Neoplasm Metastasis
Serine/threonine-protein kinase A-Raf inhibitor
LY-3009120
×
Maximum Phase:
1
First Approval:
None
UNII:
1GDT36RARO
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AG-24322
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma, Non-Hodgkin
Cyclin-dependent kinase 1 inhibitor
AG-24322
×
Maximum Phase:
1
First Approval:
None
UNII:
926F8X7TNO
Molecule Type:
Small molecule
Molecular Formula:
C23H20F2N6
Molecular Weight:
418.45
AlogP:
2.95
PSA:
73.7
HBD:
3.0
HBA:
#RotB:
4.0
Source:
E-2212
1
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Unknown
E-2212
×
Maximum Phase:
1
First Approval:
None
UNII:
V9KGF25853
Molecule Type:
Small molecule
Molecular Formula:
C25H23F3N6O
Molecular Weight:
480.49
AlogP:
5.29
PSA:
70.65
HBD:
0.0
HBA:
#RotB:
5.0
Source:
LISAVANBULIN
1
Small molecule
Investigational
Unknown
Unknown
Glioblastoma; Neoplasms
Unknown
LISAVANBULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
5PT0QP06X5
Molecule Type:
Small molecule
Molecular Formula:
C26H29N9O3
Molecular Weight:
515.58
AlogP:
2.69
PSA:
190.77
HBD:
4.0
HBA:
#RotB:
13.0
Source:
RG7893
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Sodium channel protein type IX alpha subunit blocker
RG7893
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AR-42
1
Small molecule
Investigational
Unknown
Unknown
Multiple Myeloma
Unknown
AR-42
×
Maximum Phase:
1
First Approval:
None
UNII:
E0GG29V0AQ
Molecule Type:
Small molecule
Molecular Formula:
C18H20N2O3
Molecular Weight:
312.37
AlogP:
3.18
PSA:
78.43
HBD:
3.0
HBA:
#RotB:
5.0
Source:
AZD-3043
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AZD-3043
×
Maximum Phase:
1
First Approval:
None
UNII:
372AB76LQL
Molecule Type:
Small molecule
Molecular Formula:
C19H29NO5
Molecular Weight:
351.44
AlogP:
2.83
PSA:
65.07
HBD:
0.0
HBA:
#RotB:
11.0
Source:
16.ALPHA.-BROMOEPIANDROSTERONE
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
16.ALPHA.-BROMOEPIANDROSTERONE
×
Maximum Phase:
1
First Approval:
None
UNII:
9735KA370S
Molecule Type:
Small molecule
Molecular Formula:
C19H29BrO2
Molecular Weight:
369.34
AlogP:
4.33
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
0.0
Source:
GSK-923295A
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
GSK-923295A
×
Maximum Phase:
1
First Approval:
None
UNII:
072702W9QD
Molecule Type:
Small molecule
Molecular Formula:
C32H38ClN5O4
Molecular Weight:
592.14
AlogP:
4.51
PSA:
108.2
HBD:
3.0
HBA:
#RotB:
12.0
Source:
MAFOSFAMIDE
1
Small molecule
Investigational
Unknown
Unknown
Central Nervous System Neoplasms; Leukemia; Lymphoma; Meningeal Neoplasms
Unknown
MAFOSFAMIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
5970HH9923
Molecule Type:
Small molecule
Molecular Formula:
C9H19Cl2N2O5PS2
Molecular Weight:
401.27
AlogP:
1.83
PSA:
95.94
HBD:
2.0
HBA:
#RotB:
9.0
Source:
VLX-1005
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
VLX-1005
×
Maximum Phase:
1
First Approval:
None
UNII:
JKU4XCC48Y
Molecule Type:
Small molecule
Molecular Formula:
C21H19N3O4S2
Molecular Weight:
441.53
AlogP:
4.42
PSA:
100.55
HBD:
3.0
HBA:
#RotB:
7.0
Source:
MITOQUINOL CATION
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MITOQUINOL CATION
×
Maximum Phase:
1
First Approval:
None
UNII:
65M41NIO61
Molecule Type:
Small molecule
Molecular Formula:
C37H46O4P+
Molecular Weight:
585.75
AlogP:
8.08
PSA:
58.92
HBD:
2.0
HBA:
#RotB:
16.0
Source:
LGX-806
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Serine/threonine-protein kinase B-raf inhibitor
LGX-806
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RODATRISTAT ETHYL
1
Small molecule
Investigational
Unknown
Unknown
Hypertension, Pulmonary
Tryptophan 5-hydroxylase 1 inhibitor
RODATRISTAT ETHYL
×
Maximum Phase:
1
First Approval:
None
UNII:
507FY6OL37
Molecule Type:
Small molecule
Molecular Formula:
C29H31ClF3N5O3
Molecular Weight:
590.05
AlogP:
5.57
PSA:
102.6
HBD:
2.0
HBA:
#RotB:
7.0
Source:
TRANSTORINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
TRANSTORINE
×
Maximum Phase:
1
First Approval:
None
UNII:
H030S2S85J
Molecule Type:
Small molecule
Molecular Formula:
C10H7NO3
Molecular Weight:
189.17
AlogP:
1.23
PSA:
70.16
HBD:
2.0
HBA:
#RotB:
1.0
Source:
COCAETHYLENE
1
Small molecule
Investigational
Unknown
Unknown
Cocaine-Related Disorders
Unknown
COCAETHYLENE
×
Maximum Phase:
1
First Approval:
None
UNII:
FJO3071W5Y
Molecule Type:
Small molecule
Molecular Formula:
C18H23NO4
Molecular Weight:
317.39
AlogP:
2.26
PSA:
55.84
HBD:
0.0
HBA:
#RotB:
4.0
Source:
MK-6325
1
Small molecule
Investigational
Unknown
Unknown
Hepatitis C
Unknown
MK-6325
×
Maximum Phase:
1
First Approval:
None
UNII:
59LD48P07K
Molecule Type:
Small molecule
Molecular Formula:
C42H56N6O9S
Molecular Weight:
821.01
AlogP:
4.76
PSA:
195.22
HBD:
3.0
HBA:
#RotB:
4.0
Source:
LY-2780301
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma; Neoplasm Metastasis
Ribosomal protein S6 kinase (P70S6K) inhibitor
LY-2780301
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ZOTATIFIN
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Severe Acute Respiratory Syndrome
Unknown
ZOTATIFIN
×
Maximum Phase:
1
First Approval:
None
UNII:
2EWN8Z05CN
Molecule Type:
Small molecule
Molecular Formula:
C28H29N3O5
Molecular Weight:
487.56
AlogP:
2.78
PSA:
108.07
HBD:
2.0
HBA:
#RotB:
6.0
Source:
ARQ-736
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Serine/threonine-protein kinase B-raf inhibitor
ARQ-736
×
Maximum Phase:
1
First Approval:
None
UNII:
Y2H4S74Y8U
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RACLOPRIDE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RACLOPRIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
430K3SOZ7G
Molecule Type:
Small molecule
Molecular Formula:
C15H20Cl2N2O3
Molecular Weight:
347.24
AlogP:
2.92
PSA:
61.8
HBD:
2.0
HBA:
#RotB:
5.0
Source:
GS-441524
1
Small molecule
Investigational
Unknown
Unknown
Severe Acute Respiratory Syndrome
Unknown
GS-441524
×
Maximum Phase:
1
First Approval:
None
UNII:
1BQK176DT6
Molecule Type:
Small molecule
Molecular Formula:
C12H13N5O4
Molecular Weight:
291.27
AlogP:
-1.86
PSA:
149.92
HBD:
4.0
HBA:
#RotB:
2.0
Source:
OPROZOMIB
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular; Multiple Myeloma; Neoplasms; Waldenstrom Macroglobulinemia
26S proteosome inhibitor
OPROZOMIB
×
Maximum Phase:
1
First Approval:
None
UNII:
MZ37792Y8J
Molecule Type:
Small molecule
Molecular Formula:
C25H32N4O7S
Molecular Weight:
532.62
AlogP:
0.41
PSA:
148.25
HBD:
3.0
HBA:
#RotB:
14.0
Source:
FEDOVAPAGON
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
FEDOVAPAGON
×
Maximum Phase:
1
First Approval:
None
UNII:
VX2GBO4I0V
Molecule Type:
Small molecule
Molecular Formula:
C27H34N4O3
Molecular Weight:
462.59
AlogP:
3.74
PSA:
72.96
HBD:
1.0
HBA:
#RotB:
4.0
Source:
INULINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
INULINE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C32H46N2O8
Molecular Weight:
586.73
AlogP:
1.72
PSA:
132.94
HBD:
3.0
HBA:
#RotB:
8.0
Source:
GSK2816126
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Histone-lysine N-methyltransferase EZH2 inhibitor
GSK2816126
×
Maximum Phase:
1
First Approval:
None
UNII:
W4OGW9QZ97
Molecule Type:
Small molecule
Molecular Formula:
C31H38N6O2
Molecular Weight:
526.69
AlogP:
4.63
PSA:
95.05
HBD:
3.0
HBA:
#RotB:
7.0
Source:
VS-4718
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Biphenotypic, Acute; Leukemia, Myeloid, Acute; Pancreatic Neoplasms
Focal adhesion kinase 1 inhibitor
VS-4718
×
Maximum Phase:
1
First Approval:
None
UNII:
L2BD0MW4OL
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PALOMID-529
1
Small molecule
Investigational
Unknown
Unknown
Macular Degeneration
Serine/threonine-protein kinase mTOR inhibitor
PALOMID-529
×
Maximum Phase:
1
First Approval:
None
UNII:
XV9409EWG4
Molecule Type:
Small molecule
Molecular Formula:
C24H22O6
Molecular Weight:
406.43
AlogP:
4.6
PSA:
78.13
HBD:
1.0
HBA:
#RotB:
6.0
Source:
BIIF 1149 BS
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BIIF 1149 BS
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
8-CHLOROADENOSINE
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Unknown
8-CHLOROADENOSINE
×
Maximum Phase:
1
First Approval:
None
UNII:
PA05MFH3I7
Molecule Type:
Small molecule
Molecular Formula:
C10H12ClN5O4
Molecular Weight:
301.69
AlogP:
-1.33
PSA:
139.54
HBD:
4.0
HBA:
#RotB:
2.0
Source:
1
2
…
65
66
67
68
69
70
71
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA